155 related articles for article (PubMed ID: 30864860)
1. Toward a Scientific Nutritional Supplement Combination for Prostatism and Erectile Dysfunction I: From Known Pharmacology to Clinical Testing.
Pyke RE
J Med Food; 2019 May; 22(5):529-537. PubMed ID: 30864860
[TBL] [Abstract][Full Text] [Related]
2. Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction.
Cormio L; De Siati M; Lorusso F; Selvaggio O; Mirabella L; Sanguedolce F; Carrieri G
Urology; 2011 Jan; 77(1):119-22. PubMed ID: 21195829
[TBL] [Abstract][Full Text] [Related]
3. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction.
Broderick GA; Brock GB; Roehrborn CG; Watts SD; Elion-Mboussa A; Viktrup L
Urology; 2010 Jun; 75(6):1452-8. PubMed ID: 20163842
[TBL] [Abstract][Full Text] [Related]
4. Herbal Dietary Supplements for Erectile Dysfunction: A Systematic Review and Meta-Analysis.
Borrelli F; Colalto C; Delfino DV; Iriti M; Izzo AA
Drugs; 2018 Apr; 78(6):643-673. PubMed ID: 29633089
[TBL] [Abstract][Full Text] [Related]
5. Exo-Clinical Trials of Nutritional Supplements for Sexual Dysfunction: Precedents, Principles, and Protocols.
Pyke RE
Sex Med Rev; 2019 Apr; 7(2):251-258. PubMed ID: 30301704
[TBL] [Abstract][Full Text] [Related]
6. PDE5 inhibitors for LUTS.
Mouli S; McVary KT
Prostate Cancer Prostatic Dis; 2009; 12(4):316-24. PubMed ID: 19687801
[TBL] [Abstract][Full Text] [Related]
7. The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors.
Köhler TS; McVary KT
Eur Urol; 2009 Jan; 55(1):38-48. PubMed ID: 18783872
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension.
McVary KT; Kaufman J; Young JM; Tseng LJ
Int J Clin Pract; 2007 Nov; 61(11):1843-9. PubMed ID: 17887993
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II.
Moyad MA; Barada JH; Lue TF; Mulhall JP; Goldstein I; Fawzy A;
Urol Clin North Am; 2004 May; 31(2):259-73. PubMed ID: 15123406
[TBL] [Abstract][Full Text] [Related]
10. Levels of l-arginine and l-citrulline in patients with erectile dysfunction of different etiology.
Barassi A; Corsi Romanelli MM; Pezzilli R; Damele CA; Vaccalluzzo L; Goi G; Papini N; Colpi GM; Massaccesi L; Melzi d'Eril GV
Andrology; 2017 Mar; 5(2):256-261. PubMed ID: 28178400
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Kim SW; Park NC; Lee SW; Yang DY; Park JK; Moon DG; Yang SK; Lee SW; Moon KH; Ahn TY; Kim SW; Park K; Min KS; Ryu JK; Son H; Jung J; Hyun JS
J Sex Med; 2017 Aug; 14(8):1018-1027. PubMed ID: 28760246
[TBL] [Abstract][Full Text] [Related]
12. Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Gacci M; Andersson KE; Chapple C; Maggi M; Mirone V; Oelke M; Porst H; Roehrborn C; Stief C; Giuliano F
Eur Urol; 2016 Jul; 70(1):124-133. PubMed ID: 26806655
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia.
Tamimi NA; Mincik I; Haughie S; Lamb J; Crossland A; Ellis P
BJU Int; 2010 Sep; 106(5):674-80. PubMed ID: 20184577
[TBL] [Abstract][Full Text] [Related]
14. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
Lehrer S; Cesaretti J; Stone NN; Stock RG
BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
[TBL] [Abstract][Full Text] [Related]
15. Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results.
Herrmann HC; Levine LA; Macaluso J; Walsh M; Bradbury D; Schwartz S; Mohler ER; Kimmel SE
J Sex Med; 2006 Mar; 3(2):303-8. PubMed ID: 16490024
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of PDE5 inhibitors in LUTS and ED: the NO-cGMP pathway.
Giuliano F
Eur Urol; 2009 Jan; 55(1):49-51. PubMed ID: 18938025
[No Abstract] [Full Text] [Related]
17. Efficacy and Safety of Common Ingredients in Aphrodisiacs Used for Erectile Dysfunction: A Review.
Srivatsav A; Balasubramanian A; Pathak UI; Rivera-Mirabal J; Thirumavalavan N; Hotaling JM; Lipshultz LI; Pastuszak AW
Sex Med Rev; 2020 Jul; 8(3):431-442. PubMed ID: 32139335
[TBL] [Abstract][Full Text] [Related]
18. Effects of Korean ginseng berry extract on sexual function in men with erectile dysfunction: a multicenter, placebo-controlled, double-blind clinical study.
Choi YD; Park CW; Jang J; Kim SH; Jeon HY; Kim WG; Lee SJ; Chung WS
Int J Impot Res; 2013; 25(2):45-50. PubMed ID: 23254461
[TBL] [Abstract][Full Text] [Related]
19. Kaempferia parviflora ethanol extract improves self-assessed sexual health in men: a pilot study.
Stein RA; Schmid K; Bolivar J; Swick AG; Joyal SV; Hirsh SP
J Integr Med; 2018 Jul; 16(4):249-254. PubMed ID: 29880257
[TBL] [Abstract][Full Text] [Related]
20. Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment.
Roehrborn CG; Kaminetsky JC; Auerbach SM; Montelongo RM; Elion-Mboussa A; Viktrup L
BJU Int; 2010 Feb; 105(4):502-7. PubMed ID: 19732051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
